In conclusion, our study confirmed that exosomal LINC00853 is a potential biomarker of gastric cancer and revealed its regulatory effects on the MAP17/PDZK1/AKT pathway in gastric cancer. This evidence concerns the gene LINC00853 and gastric cancer.